On November 27, FANGZHOU JIANKE (06086) and TENCENT Health jointly unveiled their "AI+Chronic Disease Management" solution, marking a new phase in China's chronic disease management sector. The collaboration aims to provide industry partners with end-to-end support—from technical validation to implementation and large-scale deployment—injecting fresh momentum into intelligent, compliant, and efficient industry development.
Leveraging their respective expertise, the two companies complement each other's strengths. FANGZHOU JIANKE, a leading "AI+Chronic Disease Management" service platform in China, has developed a unique technological edge and accumulated practical experience through its innovative "AI+H2H (Hospital to Home) Smart Healthcare Ecosystem." Meanwhile, TENCENT Cloud, a top-tier cloud service provider, excels in key technologies such as cloud computing, big data, and artificial intelligence. Together, they will provide robust technical support for digital and intelligent upgrades in the "AI+Chronic Disease Management" field.
**Proven Efficacy: AI's Value in Chronic Disease Management** This industry-oriented solution is grounded in FANGZHOU JIANKE's validated practices, with its effectiveness demonstrated by substantial business data. In October alone, the platform's AI feature users surged 2.4 times month-on-month, reflecting strong growth momentum.
AI technology has particularly excelled in addressing real user pain points. For instance, the "Report Interpretation" feature in FANGZHOU JIANKE's Doctor App effectively tackles patients' common struggle with understanding medical reports. Since its launch, user inquiries and engagement have risen significantly, indicating growing trust in AI-powered services.
To ensure reliability in the highly sensitive healthcare sector, FANGZHOU JIANKE has implemented multiple safety measures, including knowledge base optimization, model supervision, and compliance upgrades, minimizing risks associated with large language models in medical scenarios.
These achievements stem from FANGZHOU JIANKE's AI+H2H ecosystem strategy, which integrates proprietary AI models into workflows, creating a closed-loop service system covering the entire chronic disease management cycle. Key features include: - **AI Health Assistant**: Offers 24/7 health consultations, knowledge Q&A, report analysis, and smart triage. - **AI Medication Helper**: Supports practical functions like medication identification via photo. - **AI Content Assistant**: Enhances professional content production through video analysis, script generation, and AI editing, bridging information gaps between doctors and patients.
**Empowering the Industry with Scalable AI Solutions** Building on proven results, FANGZHOU JIANKE and TENCENT Health are deepening their collaboration to transform validated AI capabilities into industry-wide solutions. The new offering combines FANGZHOU JIANKE's vertical expertise with TENCENT Health's comprehensive service infrastructure, enabling secure, efficient, and compliant digital transformation for partners.
Key technical foundations include: - A large-model framework powered by TENCENT Health's TI platform, enabling efficient tuning and optimization. - TENCENT Health's vector database, enabling millisecond-level semantic search and improving content accuracy via RAG architecture. - Advanced security measures, including TENCENT Health's intelligent WAF for healthcare scenarios, ensuring compliance and data protection.
The solution merges FANGZHOU JIANKE's deep understanding of internet healthcare with TENCENT Health's stable, secure, and high-performance infrastructure, facilitating scalable AI adoption in medicine.
This partnership aligns with China's national policy to promote "AI+Healthcare" applications, as outlined in recent guidelines by the National Health Commission. Moving forward, FANGZHOU JIANKE plans to drive innovation alongside TENCENT Health and other partners, advancing chronic disease management toward greater efficiency, precision, and accessibility, contributing to the "Healthy China 2030" vision and ushering in a new era of smart healthcare.
Comments